A 57-year-old male patient was stopped by police for erratic driving, The patient was obviously drunk. After his family was contacted, it was found that the patient started heavy drinking recently and also had a markedly increased appetite. He became unconscious while in police custody and was transferred to the hospital. During his workup investigation, the result of a angiogram of the pancreas is shown in the picture. What is the most likely diagnosis?

This patient most likely has pancreatic insulinoma. All of his symptoms are consistent with recurrent episodes of hypoglycemia. The hallmark of insulinoma (pancreatic â-cell tumors) is symptomatic hypoglycemia caused by unregulated insulin secretion. These tumors are the second most common functioning tumors of the islet cells (gastrinomas are most common). Patients are usually in the 5th to 7th decade of life. Whipple’s triad (classic presentation of insulinoma) consists of fasting hypoglycemia, symptoms of hypoglycemia, and prompt relief of symptoms following intravenous injection of glucose. Weight gain may occur due to increased food intake to counteract the symptoms of hypoglycemia. Symptoms of hypoglycemia include slurred speech, visual disturbances, psychological alterations, confusion, headache, and ultimately coma and death. Secondary release of catecholamines causes pallor, palpitations, diaphoresis, cardiac arrhythmias, and tremulousness. In the early course, symptoms are intermittent (due to episodic release of insulin). Since those tumors are highly symptomatic, they are usually discovered while still small (multiple tumors are found in about 10% of cases), and those are malignant in about 10% of cases. These tumors are seen also as a part of multiple-endocrine-neoplasia-syndrome type I. Diagnosis is made by demonstrating hypoglycemia and an inadequate response of insulin to the hypoglycemia (by fasting under close supervision most patients develop hypoglycemia within 24 hours – test may take 72 hours). Diagnosis depends on demonstration of inadequate insulin suppression with low blood glucose levels. In addition, rising cortisol level should be demonstrated to exclude hypothalamic-pituitary-adrenal insufficiency. Exogenous administration of insulin and sulfonylurea also has to be excluded as well as severe liver failure and tumors that secrete insulin like growth factors.
In this case the tumor is demonstrated as a highly vascular lesion on digital subtraction arteriography of the pancreas, but it is now much more common to use CT scanning (50% sensitive), endoscopic ultrasonography (80-90% sensitive), and angiography with selective venous sampling (80% sensitive) to detect those tumors.